Browsing: Orphan Drug Designation
ENB Therapeutics’ Orphan Drug, Endothelin Receptor Type B Target for Resistant Cancers
By Radhika Shah
Last week, President and Co-Founder Sumayah Jamhal presented her company, ENB Therapeutics, at the 2023 Immuno-Oncology 360 Degree Conference in…
Subscribe to Updates
Get the latest news from Biotech Metropolitan Women.
Biotech Metropolitan Women ©2018-2023